Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN5A | Q14524 | 1/20 | 0.50 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.50 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1952758 | 0.85 | SCN5A (0.58) | SCN5ASCN9ASCN10A | |
| SCHEMBL13835730 | 0.82 | SCN5A (0.53) | SCN5ASCN9ASCN10A | |
| SCHEMBL6895916 | 0.81 | CYP1A2 (0.47) | — | |
| SCHEMBL13836155 | 0.79 | SCN5A (0.57) | SCN5ASCN9ASCN10A | |
| SCHEMBL6894273 | 0.77 | L3MBTL1 (0.46) | — | |
| SCHEMBL17071808 | 0.76 | SCN5A (0.65) | SCN5ASCN9ASCN10A | |
| SCHEMBL17069170 | 0.76 | SCN5A (0.61) | SCN5ASCN9ASCN10A | |
| SCHEMBL4023092 | 0.76 | SCN5A (0.49) | SCN5ASCN9ASCN10A | |
| SCHEMBL1927023 | 0.76 | SCN5A (0.49) | SCN5ASCN9ASCN10A | |
| SCHEMBL2928280 | 0.75 | SCN5A (0.49) | SCN5ASCN9ASCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120295866-A1 | Synthesis And Use Of Glycoside Pro-Drug Analogs | NuTek Pharma Ltd. | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295866-A1 | Synthesis And Use Of Glycoside Pro-Drug Analogs | GCG, CYP3A5, UGT1A6 | SCN5A 1423/4885SCN9A 3539/4885SCN10A 2714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.